Afuco™ Anti-Human MMP13 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-MMP13 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies directed to the antigen MMP-13 are used for the treatment of diseases associated with the activity and/or overproduction of MMP-13. MMP-13 is expressed at elevated levels in cancers, degenerative bone diseases, and cardiovascular diseases. Inhibition of the biological activity of MMP-13 can delay the progression of symptoms caused by such diseases or conditions and other desired effects.
Supplier Creative Biolabs
Product # AFC-510CL
Pricing Inquiry
Host Human
Target MMP13
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Feedback